PT. Dataindo Inti Swakarsa

          PT. Dataindo Inti Swakarsa
Membership | FAQ | About | Contact | Home 

Indonesia Companies - Indonesia Industry Reports - Indonesia Trade Reports - Indonesia Bilateral Reports
SEARCH  
MEMBER LOGIN    

Products

Latest Updates

Related Reports

Related Indonesia Industry Reports
•C3412 - Paper and Cardboard Box Manufacturing
Related Tariffs and Trade Reports
• For paper making purposes. HS: 4707.10.00.10
• Sterilisation indicator strips and stapes. HS: 3822.00.30.00
• Sterilisation indicator strips and stapes. HS: 3822.00.30.00
• Sterilisation indicator strips and stapes. HS: 3822.00.30.00
• Cartons, boxes and cases, of corrugated paper or paperboard. HS: 4819.10.00.00
• Sterilisation indicator strips and stapes. HS: 3822.00.30.00
• Of a kind used for marking cement bags. HS: 4804.21.10.00
• Selfcopy paper. HS: 4809.20.00.00
• Other. HS: 4810.13.90.90
• Electrocardiograph, ultrasonography, spiromoter, electroencephalograp and fetal monitoring papers, of a width of 15 cm or less. HS: 4810.13.40.00
• Weighing not more than 55 g/m2. HS: 4801.00.10.00
• Sterilisation indicator strips and stapes. HS: 3822.00.30.00
Company News
Suparma Profit for Expansion
Bisnis Indonesia, page B2, 2006-06-21
PT Suparma Tbk will not share dividends from its net profit of Rp.8.1 billion because it will be used for the company including expanding the business to the tissue industry with an investment of Rp.5 million. In 2005, the company’s performance was satisfying. Sales value increased from Rp.546.5 billion in 2004 to Rp.579.3 billion, up 6 percent, in 2005. This was caused by the rise in the selling price in the domestic market (8.2 percent) and export market (12.6 percent). In 2005, the company’s gross profit increased 10.6 percent to Rp.101.5 billion and its profit rose 13 percent to Rp.62.8 billion. Before, its gross profit reached Rp.91.9 billion and its profit was Rp.55.6 billion. As a result of the reorganisation in 2005, the company has deleted deficit amounting to Rp.339.3 billion. The company’s equity increased from Rp.169.9 billion to Rp.397.4 billion. Its net profit amounted to Rp.8.1 billion. At the present, the utilisation of PT Suparma’s production of paper reaches 94 percent of the set capacity of 15,000 per year or up from last year’s 92 percent.
Suparma Equity Up 138 Percent in 2005
Bisnis Indonesia, page B1, 2006-03-29
PT Suparma Tbk’s equity rose 138.7 percent Rp.405 million in 2005 compared to its number by December 2004 of Rp.169.92 billion. Meanwhile, the company’s assets increased by 21.6 percent from Rp.1.09 trillion at the end of 2004 to Rp.1.32 trillion in 2005. This is caused by the increase of stable asset account of 32.7 percent from Rp.731.83 billion to Rp.971.15 billion.
 
Suparma Tbk., PT
Indonesia Company Report
Last Update 29-January-2024
Major Businessline : Tissue, Kitchen towel, Hand towel, Paperboard,

PT. Dataindo Inti Swakarsa
3rd Floor, Gapura Raya Building
Jl. Bangka Raya No. 4, Pela Mampang Email : info@disb2b.com
Jakarta 12720, Indonesia
Selective Member’s Information US $ Select All
Address 0.66
Telephone number(s) [3] 0.66
Facsimile number(s) [1] 0.44
Email 1.00
Website 0.28
Personnel (Commissioner [5], Director [3]) 4.40
Establishment Date 0.77
Tax Number (NPWP) 0.77
Business Activity 0.44
Legality (Ownership Type, Investment Type) 0.39
Number of employees [2-Jun-10] 0.77
Certification(s) [1] 0.50
Brands / Trade Mark 0.77
Authorised Capital 3.85
Paid Up Capital 3.85
Auditor(s) [1] [2-May-08] 1.32
Shareholder(s) [5] 16.50
Number Of Shares 3.30
Share Nominal Value 3.30
Additional Information 0.88
Profit and Loss [2015,2016,2017,2018,2019]
(Net Sales, Cost of Goods Sold, Gross Profit, Operating Expense, Operating Profit (Loss), Other Income (Expense), Profit (Loss) After Tax, Growth)
Balance Sheet [2015,2016,2017,2018,2019]
(Total Assets, Current Assets, Non Current Assets, Other Assets, Total Liabilities, Current Liabilities, Long Term Liabilities, Minority, Shareholder's Equity)
 33.00
Listing History
(First Issue, Company Listing, Bonus Shares, Stock Dividen, Stock Split, Bonus Shares, Stock Dividen, Stock Dividen, Additional Listing Without HMETD)		 0.77
Ratios (Times) & Per Share Data [2015,2016,2017,2018,2019]
(PER, PBV, Current Ratio, Debt to Equity, Leverage, Gross Profit Margin, Operating Profit Margin, Net Profit Margin, Inventory Turnover, Total Assets Turnover, ROI, ROE)		 0.77
News
Suparma Restructures Debt 0.39
Suparma’s Net Profit Reaches Rp.2.31 Billion 0.39
Suparma’s Stock Trade Warrant 0.39
TOTAL PRICE (US$)(RP)
Price 100.001.650.000
Payment Method
Credit Card
Bank Transfer in US$
Bank Transfer in RP
Buy Now

 
Selective Member`s Discount Price
US$
To become a Selective Member
Register
Report Content
PROFIT AND LOSS 2020 2021 2022
Revenue 13,613,840 13,229,085 15,397,484
Cost of Goods N/A N/A N/A
Gross Profit 13,613,840 13,229,085 15,397,484
Net Profit Before Tax 3,139,711 4,528,733 5,123,618
The data above is sample data only
Balance Sheet (In RP Millions) 2020 2021 2022
Total Assets 133,260,087 149,168,842 150,180,752
Non Current Assets 1,888,511 1,935,151 2,024,748
Other Assets 2,885,953 4,075,426 50,103,265
Cash on Hand in Bank 47,751,808 43,551,174 27,213,874
Placement in other Bank 3,697,885 2,558,909 7,344,934
Notes & Securities 48,516,569 57,691,639 10,714,256
Loans 28,329,341 39,280,369 52,778,750
Total Liabilities 120,634,642 135,243,441 134,333,598
Cash
Minority 776 990 1,268
Total Deposits 118,251,011 131,985,222 129,555,406
Call Money 796,988 672,224 720,321
Notes Issued 252,202 425,039 652,439
Borrowings 219,652 484,127 525,316
Other Liabilities 1,114,013 1,675,839 2,878,848
Shareholder"s Equity 12,625,445 13,925,401 15,847,154
The data above is sample data only